[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[2]
|
袁思依, 李景南. 分子标志物在结直肠癌筛查中的应用[J]. 中国实用内科杂志, 2018, 38(9): 788-791.
|
[3]
|
Fossum, K. and Whitaker, J.R. (1968) Ficin and Papain Inhibitor from Chicken Egg White. Archives of Biochemistry and Biophysics, 125, 367-375. https://doi.org/10.1016/0003-9861(68)90672-3
|
[4]
|
Anastasi, A., Brown, M.A., Kembhavi, A.A., Nicklin, M.J.H., Sayers, C.A., Sunter, D.C., et al. (1983) Cystatin, a Protein Inhibitor of Cysteine Proteinases. Improved Purification from Egg White, Characterization, and Detection in Chicken Serum. Biochemical Journal, 211, 129-138. https://doi.org/10.1042/bj2110129
|
[5]
|
Shamsi, A. and Bano, B. (2017) Journey of Cystatins from Being Merethiol Protease Inhibitors to at Heart of Many Pathological Conditions. International Journal of Biological Macromolecules, 102, 674-693.
https://doi.org/10.1016/j.ijbiomac.2017.04.071
|
[6]
|
Abrahamson, M., Barrett, A.J., Salvesen, G. and Grubb, A. (1986) Isolation of Six Cysteine Proteinase Inhibitors from Human Urine. Their Physicochemical and Enzyme Kinetic Properties and Concentrations in Biological Fluids. Journal of Biological Chemistry, 261, 11282-11289. https://doi.org/10.1016/S0021-9258(18)67380-6
|
[7]
|
Ni, J., Abrahamson, M., Zhang, M., Fernandez, M.A., Grubb, A., Su, J., et al. (1997) Cystatin E Is a Novel Human Cysteine Proteinase Inhibitor with Structural Resemblance to Family 2 Cystatins. Journal of Biological Chemistry, 272, 10853-10858. https://doi.org/10.1074/jbc.272.16.10853
|
[8]
|
Ni, J., Fernandez, M.A., Danielsson, L., Chillakuru, R.A., Zhang, J., Grubb, A., et al. (1998) Cystatin F Is a Glycosylated Human Low Molecular Weight Cysteine Proteinase Inhibitor. Journal of Biological Chemistry, 273, 24797-24804.
https://doi.org/10.1074/jbc.273.38.24797
|
[9]
|
Hook, V., Funkelstein, L., Wegrzyn, J., Bark, S., Kindy, M. and Hook, G. (2012) Cysteine Cathepsins in the Secretory Vesicle Produce Active Peptides: Cathepsin L Generates Peptide Neurotransmitters and Cathepsin B Produces Beta-Amyloid of Alzheimer’s Disease. Biochimica et Biophysica Acta (BBA)—Proteins and Proteomics, 1824, 89-104.
https://doi.org/10.1016/j.bbapap.2011.08.015
|
[10]
|
Cheng, X.W., Huang, Z., Kuzuya, M., Okumura, K. and Murohara, T. (2011) Cysteine Protease Cathepsins in Atherosclerosis-Based Vascular Disease and Its Complications. Hypertension, 58, 978-986.
https://doi.org/10.1161/HYPERTENSIONAHA.111.180935
|
[11]
|
Harlozinska, A. (2005) Progress in Molecular Mechanisms of Tumor Metastasis and Angiogenesis. Anticancer Research, 25, 3327-3333.
|
[12]
|
Satoko, I., Eiichi, S. and Kazuo, S. (1984) Isolation and Amino Acid Sequence of SAP-1, an Acidic Protein of Human Whole Saliva, and Sequence Homology with Human Gamma-Trace. Journal of Biochemistry, 96, 489-498.
https://doi.org/10.1093/oxfordjournals.jbchem.a134861
|
[13]
|
Isemura, S., Saitoh, E. and Sanada, K. (1986) Characterization of a New Cysteine Proteinase Inhibitor of Human Saliva, Cystatin SN, Which Is Immunologically Related to Cystatin S. FEBS Letters, 198, 14514-14519.
https://doi.org/10.1016/0014-5793(86)81201-7
|
[14]
|
Isemura, S., Saitoh, E. and Sanada, K. (1987) Characterization and Amino Acid Sequence of a New Acidic Cysteine Proteinase Inhibitor (Cystatin SA) Structurally Closely Related to Cystatin S, from Human Whole Saliva. Journal of Biochemistry, 102, 693-704. https://doi.org/10.1093/oxfordjournals.jbchem.a122107
|
[15]
|
Saitoh, E., Kim, H.S., Smithies, O. and Maeda, N. (1987) Human Cysteine-Proteinase Inhibitors: Nucleotide Sequence Analysis of Three Members of the Cystatin Gene Family. Gene, 61, 329-338.
https://doi.org/10.1016/0378-1119(87)90196-X
|
[16]
|
Bobek, L.A., Aguirre, A. and Levine, M.J. (1991) Human Salivary Cystatin S. Cloning, Sequence Analysis, Hybridization in Situ and Immunocytochemistry. Biochemical Journal, 278, 627-635. https://doi.org/10.1042/bj2780627
|
[17]
|
Dickinson, D.P., Thiesse, M. and Hicks, M.J. (2002) Expression of Type 2 Cystatin Genes CST1-CST5 in Adult Human Tissues and the Developing Submandibular Gland. DNA and Cell Biology, 21, 47-65.
https://doi.org/10.1089/10445490252810311
|
[18]
|
Choi, E.H., Kim, J.T., Kim, J.H., Kim, S.Y., Song, E.Y., Kim, J.W., et al. (2009) Upregulation of the Cysteine Protease Inhibitor, Cystatin SN, Contributes to Cell Proliferation and Cathepsin Inhibition in Gastric Cancer. Clinica Chimica Acta, 406, 45-51. https://doi.org/10.1016/j.cca.2009.05.008
|
[19]
|
Yoneda, K., Iida, H., Endo, H., Hosono, K., Akiyama, T., Takahashi, H., et al. (2009) Identification of Cystatin SN as a Novel Tumor Marker for Colorectal Cancer. International Journal of Oncology, 35, 33-40.
https://doi.org/10.3892/ijo_00000310
|
[20]
|
Kim, J.T., Lee, S.J., Kang, M.A., Park, J.E., Kim, B.Y., Yoon, D.Y., et al. (2013) Cystatin SN Neutralizes the Inhibitory Effect of Cystatin C on Cathepsin B Activity. Cell Death & Disease, 4, Article No. e974.
https://doi.org/10.1038/cddis.2013.485
|
[21]
|
Zhang, W.P., Wang, Y., Tan, D. and Xing, C.G. (2020) Cystatin 2 Leads to a Worse Prognosis in Patients with Gastric Cancer. Journal of Biological Regulators and Homeostatic Agents, 34, 2059-2067.
|
[22]
|
Wang, Z., Chen, G., Wang, Q., Lu, W. and Xu, M. (2017) Identification and Validation of a Prognostic 9-Genes Expression Signature for Gastric Cancer. Oncotarget, 8, 73826-73836. https://doi.org/10.18632/oncotarget.17764
|
[23]
|
Wang, Q., Wen Y G., Li, D.P., Xia, J., Zhou, C.Z., Yan, D.W., et al. (2012) Upregulated INHBA Expression Is Associated with Poor Survival in Gastric Cancer. Medical Oncology, 29, 77-83.
|
[24]
|
Cui, J., Chen, Y., Chou W C., Sun, L., Chen, L., Suo, J., et al. (2011) An Integrated Transcriptomic and Computational Analysis for Biomarker Identification in Gastric Cancer. Nucleic Acids Research, 39, 1197-1207.
https://doi.org/10.1093/nar/gkq960
|
[25]
|
Yi, Q.Z., Jing, J.Z., Hong, J.S. and Li, D.W. (2017) Overexpression of CST4 Promotes Gastric Cancer Aggressiveness by Activating the ELFN2 Signaling Pathway. American Journal of Cancer Research, 7, 2290-2304.
|
[26]
|
Dou, Y.L., Lyu, Y.L., Zhou, X.J., He, L.F., Liu, L.H., Li, P.F., et al. (2018) Antibody-Sandwich Elisa Analysis of a Novel Blood Biomarker of CST4 in Gastrointestinal Cancers. OncoTargets and Therapy, 11, 1743-1756.
https://doi.org/10.2147/OTT.S149204
|
[27]
|
吴明兰, 林美花, 翟优, 吕朵, 张乔, 吴国兰, 等. 半胱氨酸蛋白酶抑制剂S在胃肠癌中的诊断价值研究[J]. 中国临床药理学杂志, 2021, 37(5): 503-506.
|